SCHEMBL3923957

SCHEMBL3923957

Cc1n[nH]cc1NC(=O)Nc1ncc(-c2nc(N3CCOC[C@@H]3C)cc(C3(S(C)(=O)=O)CCCC3)n2)cn1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ATR Q13535 17/20 0.51
MTOR P42345 5/20 0.49
KCNH2 Q12809 3/20 0.49
ATRIP Q8WXE1 5/20 0.48
PIK3CA P42336 5/20 0.48
TAF1 P21675 3/20 0.48
PIK3R1 P27986 3/20 0.48
PRKDC P78527 2/20 0.48
ATM Q13315 1/20 0.48
CHEK1 O14757 1/20 0.42
PDCD1 Q15116 1/20 0.42
CD274 Q9NZQ7 1/20 0.42
PIK3CD O00329 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3926774 0.92 ATR (0.49) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3926442 0.90 MTOR (0.53) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3934684 0.90 PIK3CA (0.51) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3926299 0.87 ATR (0.55) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3932925 0.87 ATR (0.44) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3924871 0.86 PIK3CA (0.54) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3926241 0.85 ATR (0.53) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3935917 0.85 ATR (0.51) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL4207140 0.84 ATR (0.51) ATRMTORKCNH2ATRIPPIK3CA
SCHEMBL3936002 0.83 PIK3CA (0.56) ATRMTORKCNH2ATRIPPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074118-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2009-07-01 EP disclosed
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed